Idiotype-induced T cell stimulation requires antigen presentation in association with HLA-DR molecules

Clinical and Experimental Immunology

Volumn 104, Issue 2, 1996, Pages 359-365

  Yi, Q ^a   Holm, G ^a   Lefvert, A K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen presentation; Idiotype; M component; MHC molecules; T cells

Indexed keywords

HLA DR ANTIGEN; IMMUNOGLOBULIN IDIOTYPE;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029864796     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.27735.x     Document Type: Article

References (49)

1. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Inst. Pasteur) 1974; 125C:373-89.
2. Jerne NK. Idiotypic networks and other preconceived ideas. Immunol Rev 1984; 79:5-25.
3. Stevenson FK, George AJT, Glennie MJ. Anti-idiotypic therapy of leukemias and lymphomas. Chem Immunol 1990; 48:126-66.
4. Levy R, Miller RA. Therapy of lymphoma directed at idiotypes. J Natl Cancer Inst Monogr 1990; 10:61-68.
5. Cohen IR, Young DB. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991; 12:5-110.
6. Lynch RG, Graff JR, Sirisinha S et al. Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci USA 1972; 69:1540-4.
7. Bogen B, Weiss S. Processing and presentation of idiotypes to MHC-restricted T cells. Int Rev Immunol 1993; 10:337-55.
8. Lynch RG, Rohrer JW, Odermatt B et al. Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol Rev 1979; 48:45-80.
9. Flood PM, Philipps C, Taupier MA et al. Regulation of myeloma growth in vitro by idiotype-specitic lymphocytes. J Immunol 1980; 124:424-30.
10. Lynch RG. Immunoglobulin-specific suppressor T cells. Adv Immunol 1987; 40:135-51.
11. Kristoffersen G, Hannestad K. Immune response to an adjuvant-free native syngeneic myeloma protein (M315). Eur J Immunol 1988; 18:1785-90.
12. Dianzani U, Pileri A, Boccadoro M et al. Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood 1988; 72:1064-8.
13. Andersson M, Holm G, Lefvert AK, Mellstedt H. Anti-idiotypic B cell lines from a patient with monoclonal gammopathy of undetermined significance. Scand J Immunol 1989; 130:489-92.
14. Bergenbrant S, Österborg A, Holm G et al. Anti-idiotypic antibodies in patients with monoclonal gammopathies. Relation to tumor load. Br J Haematol 1991; 78:66-70.
15. Bergenbrant S, Yi Q, Ösby E et al. Anti-idiotypic B lymphocytes in patients with monoclonal gammopathies. Scand J Immunol 1994; 40:216-20.
16. 2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy. Cancer Immunol Immunother 1991; 34:157-62.
17. Yi Q, Bergenbrant S, Österborg A et al. T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. Scand J Immunol 1993; 38:529-34.
18. Österborg A, Yi Q, Bergenbrant B et al. Idiotype-specific T cells in multiple myeloma stage I: an evaluation by lour different functional tests. Br J Haematol 1995; 89:110-6.
19. + T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. Cell Immunol 1993; 148:177-88.
20. Bona C, Paul WE. Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med 1979; 149:592-600.
21. Abbas AK, Perry LL, Bach BA et al. Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants. J Immunol 1980; 124:1160-6.
22. Bottomly K, Mosier DE. Antigen-specific helper T cells required for dominant idiotype expression are not H-2 restricted. J Exp Med 1981; 154:411-21.
23. Cerny J, Caulfield MJ. Stimulation of specific antibody-forming cells in antigen-primed nude mice by the adoptive transfer of syngeneic anti-idiotypic T cells. J Immunol 1981; 126:2262-6.
24. Cerny J, Smith JS, Webb C et al. Properties of anti-idiotypic T cell lines propagated with syngeneic B lymphocytes. I. T cells bind intact idiotypes and discriminate between the somatic idiotypic variants in a manner similar to the anti-idiotopic antibodies. J Immunol 1988; 141:3718-25.
25. Parra CC, Lima MS, Gazzinelli G et al. Immune responses during human Schistosomiasis mansoni. XV. Anti-idiotypic T cells can recognize and respond to anti-SEA idiotypes directly. J Immunol 1988; 140:2401-5.
26. Bogen B, Malissen B, Haas W. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur J Immunol 1986; 16:1373-8.
27. Yamamoto H, Araki K, Bitoh S et al. Cytotoxic T lymphocyte clone recognizing self idiotype: its regulatory role in antibody production. Eur J Immunol 1987; 17:719-22.
28. Mellstedt H, Björkholm M, Holm G. Intermittent mephalan and prednisone therapy in plasma cell myeloma. Acta Med Scand 1977; 202:5-9.
29. Pettersson D, Mellstedt H, Holm G et al. Monoclonal blood lymphocytes in benign monoclonal gammopathy and myeloma in relation to clinical stage. Scand J Haematol 1981; 27:287-93.
30. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36:842-54.
31. Nisonoff TA, Wissler FC, Lipman LN et al. Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulphide bonds. Arch Biochem Biophy 1960; 89:230-44.
32. Stanworth DR, Turner MW. Immunochemical analysis of human and rabbit immunoglobulins and their subunits. In: Handbook of experimental immunology. Immunochemistry 1. Weir M, ed. Chapter 12. Oxford: Blackwell Scientific Publications, 1986:1-46.
33. + B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals. Neurology 1992; 42:1081-4.
34. Holm G, Pettersson D, Mellstedt H et al. Lymphocytic subpopulation in peripheral blood of healthy persons. Characterization by surface markers and lack of selection during purification. Clin Exp Immunol 1975; 20:443-57.
35. Lundgren G, Zukoski CHF, Möller G. Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol 1968; 3:817-36.
36. Bøyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 1983; 17:429-36.
37. Jondal M, Holm G, Wigzell H. Surface markers of human T and B lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J Exp Med 1972; 136:207-15.
38. Lee K-C, Wong M, Spitzer D. Chloroquine as a probe for antigen processing by accessory cells. Tansplantation 1982; 34:150-3.
39. King CA, Wills MR, Hamblin TJ et al. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. Cell Immunol 1993; 147:411-24.
40. Braciale TJ, Braciale VL. Antigen presentation: structural themes and functional variations. Immunol Today 1991; 12:124-9.
41. Norment AM, Salter RD, Parham P et al. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988; 336:79-81.
42. Doyle C, Strominger L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330:256-9.
43. Weiss S, Bogen B. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 1989; 86:282-6.
44. Weiss S, Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell 1991; 64:767-76.
45. Rammensee H-G, Falk K, Rötzschke O. MHC molecules as peptide receptors. Curr Opin Immunol 1993; 5:35-44.
46. Chain BM, Kaye PM, Shaw M-A. The biochemistry and cell biology of antigen processing. Immunol Rev 1988; 106:33-58.
47. Kakiuchi T, Chesnut RW, Grey HM. B cells as antigen-presenting cells: the requirement for B cell activation. J Immunol 1983; 131:109-14.
48. Tony H-P, Phillips NE, Parker DC. Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell B cell cooperation. J Exp Med 1985; 162:1695-708.
49. Casten LA, Pierce SK. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J Immunol 1988; 140:404-10.